Abeona Therapeutics Activates Second Clinical Trial Site in EB-101 Pivotal Phase 3…
NEW YORK and CLEVELAND, July 23, 2021 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced the activation of a…